三级片无码高清免费国产,中文字幕一区二区三区乱,国内精品久久久久久99蜜桃,亚洲一区电影网站在线观看

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

亚洲色图校园春色欧美日韩| 亚洲网址在线观看你懂的| 亚洲AV永久无码精品的| 91成人精品国语自产拍| 久久变态刺激另类sm| 亚洲日韩精品欧美一区二区| 亚洲av永久无码精品一福利| 经典三级第一页在线观看| 日韩精品 中文字幕第一| 无码精品av久久久奶水| 久久精品蜜芽亚洲国产a| 亚洲欧美日韩xxxxx| 国产高清久久久国产精品| 欧美日韩国产在线一区二区| 国产真实偷综合在线视频| 国产 欧美 亚洲 精品| 国产精品白浆一区二区亚洲| 精品国产一区二区三区av| 校园现代激情亚洲中文字幕| 亚洲AV无码国产精品久| 成人区精品人妻人妻av| 中文字幕亚洲精品第十页| 国产精品视频| 一区二区三区有码在线播放| 国产剧情av精品迷奷| 久久九九国产精品怡红院| 欧美精品午夜久久久久'久| 粉色视频污在线网站入口| 小屁眼白浆在线| 亚洲精品二区360偷拍| 粗大的内捧猛烈进出在线视频| 亚洲第一欧美一区二区精品| 伊在人亚洲香蕉精品播放| 亚洲AV成人无码网站…| 伊人色爱久久综合网亚洲| 亚洲欧美日本中文字不卡| 年轻的母亲在线观看韩国| 无码熟妇人妻AV在线影片免费| 午夜欧美日韩精品一区二区| 欧美精品亚洲精品小说区| 亚洲伊人av天堂有码在线|